IL18 Receptor Signaling Inhibits Intratumoral CD8
T-cell migration
T-cell plasticity
cytokines
fluorophore
intravital two-photon microscopy animal models for intravital imaging
live cell imaging
pancreatic carcinoma
pausing phases/arrest coefficient
tumor spheroid coculture model
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
31 01 2023
31 01 2023
Historique:
received:
15
12
2022
revised:
22
01
2023
accepted:
24
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
In pancreatic ductal adenocarcinoma (PDAC), the infiltration of CD8
Identifiants
pubmed: 36766797
pii: cells12030456
doi: 10.3390/cells12030456
pmc: PMC9913970
pii:
doi:
Substances chimiques
Interleukin-18
0
Il18r1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Oncol Rep. 2020 Apr;43(4):1113-1124
pubmed: 32323780
Front Oncol. 2020 Jun 26;10:916
pubmed: 32695665
Science. 2009 Jun 12;324(5933):1457-61
pubmed: 19460966
Gut. 2019 Jan;68(1):159-171
pubmed: 30177543
J Immunol. 1992 Jul 1;149(1):260-8
pubmed: 1351501
J Immunol. 2005 May 1;174(9):5856-63
pubmed: 15843590
Trends Immunol. 2012 Aug;33(8):406-12
pubmed: 22608996
Science. 2003 Dec 5;302(5651):1704-9
pubmed: 14657486
Immunity. 2014 Feb 20;40(2):235-247
pubmed: 24440150
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
J Clin Invest. 2014 Jun;124(6):2425-40
pubmed: 24812664
Mol Cancer. 2018 Nov 17;17(1):158
pubmed: 30447690
J Clin Invest. 2008 Apr;118(4):1390-7
pubmed: 18357341
J Exp Med. 2006 Nov 27;203(12):2749-61
pubmed: 17116735
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
J Exp Med. 2013 Apr 8;210(4):757-74
pubmed: 23530125
Nature. 2004 Jan 8;427(6970):154-9
pubmed: 14712275
J Innate Immun. 2022;14(3):207-217
pubmed: 34619679
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Clin Cancer Res. 2014 Dec 1;20(23):5937-5945
pubmed: 25278454
Elife. 2020 May 19;9:
pubmed: 32427565
Science. 2006 Sep 29;313(5795):1972-5
pubmed: 16931720
J Exp Med. 2007 Feb 19;204(2):345-56
pubmed: 17261634
Nat Immunol. 2008 Sep;9(9):960-9
pubmed: 18711433
Int J Cancer. 2011 Feb 15;128(4):897-907
pubmed: 20473889
Science. 2002 Jun 7;296(5574):1869-73
pubmed: 12016203
J Immunol. 2007 Sep 1;179(5):3332-41
pubmed: 17709550
J Exp Med. 1998 May 4;187(9):1383-93
pubmed: 9565631
Front Immunol. 2017 Mar 22;8:309
pubmed: 28382036
Bioessays. 2005 Jun;27(6):625-32
pubmed: 15892111
Cancer Immunol Res. 2014 Oct;2(10):970-80
pubmed: 25038199
Nat Med. 2011 Apr;17(4):500-3
pubmed: 21460848
J Clin Invest. 2012 Oct;122(10):3718-30
pubmed: 22945631
Cell. 2021 Sep 16;184(19):5031-5052.e26
pubmed: 34534465
Front Immunol. 2015 Oct 12;6:500
pubmed: 26528284
Am J Cancer Res. 2018 Apr 01;8(4):566-583
pubmed: 29736304
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Cancer Res. 1984 Feb;44(2):717-26
pubmed: 6692374
Cancer Lett. 2016 Oct 10;381(1):259-68
pubmed: 26968250
Cancer Immunol Immunother. 2011 Aug;60(8):1097-107
pubmed: 21547597
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
J Exp Med. 2005 Jun 6;201(11):1805-14
pubmed: 15939794
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10480-5
pubmed: 22699511